Cargando…
The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation
T cells defend against cancer and viral infections by rapidly scanning the surface of target cells seeking specific peptide antigens. This key process in adaptive immunity is sparked upon T cell receptor (TCR) binding of antigens within cell-cell junctions stabilized by integrin (LFA-1)/intercellula...
Autores principales: | Ma, Victor Pui-Yan, Hu, Yuesong, Kellner, Anna V., Brockman, Joshua M., Velusamy, Arventh, Blanchard, Aaron T., Evavold, Brian D., Alon, Ronen, Salaita, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880789/ https://www.ncbi.nlm.nih.gov/pubmed/35213231 http://dx.doi.org/10.1126/sciadv.abg4485 |
Ejemplares similares
-
ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway
Publicado: (1993) -
DNA Origami Tension Sensors (DOTS) to study T cell receptor mechanics at membrane junctions
por: Hu, Yuesong, et al.
Publicado: (2023) -
Role of LFA-1 and ICAM-1 in Cancer
por: Reina, Manuel, et al.
Publicado: (2017) -
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo
por: Guo, Peng, et al.
Publicado: (2023) -
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
por: Baulu, Estelle, et al.
Publicado: (2023)